(by Videoconference)
Minutes
Directors Present: Bill Hatanaka (Chair), Elyse Allan (Vice Chair), Jay Aspin, Jean-Robert Bernier, Adalsteinn Brown, Tom Flynn, Cally Hunt, Lynda Hawton Kitamura, Gillian Kernaghan, Jackie Moss, Paul Tsaparis
Directors not in Attendance: N/A
Ontario Health: Matthew Anderson (Chief Executive Officer), Anne Corbett (General Counsel and Executive Lead, Legal, Privacy and Risk), Ashley Potts (Program Manager, Legal, Privacy, Risk and Governance), Christine Gan (Executive Assistant, Legal, Risk, Privacy & Governance), Phuong Truong (Governance Coordinator)
Invited Guest(s): N/A
1. Chair’s Opening Remarks
The Chair welcomed Board Members to the meeting.
1.1 Call to Order
The meeting was called to order at 12:25 p.m.
1.2 Recognition of Quorum
With quorum present, the meeting was formally constituted.
1.3 Declarations of Conflict
No conflicts of interest were declared.
1.4 Approve Agenda
Upon motion duly made, seconded, and unanimously carried, the Agenda was approved as presented.
1.5 Dedication – Jay Aspin
Mr. Aspin dedicated the Board meeting to Bill Hatanaka, Ontario Health’s inaugural Board Chair. Mr. Aspin thanked Mr. Hatanaka for his leadership, time, passion and contributions over the last five years.
Mr. Tsaparis will dedicate the next Board meeting.
2. Consent Agenda
2.1 Approve December 13, 2023 Board Minutes
Upon motion duly made, seconded, and unanimously carried, the minutes of the December 13, 2023 Board meeting were approved.
3. Ontario Health Board of Directors Committee Appointments
Mr. Hatanaka provided a summary of the Committee appointments effective February 7, 2024, further to the pre-read materials.
Upon motion duly made, seconded and unanimously carried the Board of Directors of Ontario Health approved the following resolution:
BE IT RESOLVED THAT:
The Board of Directors approves the following Committee appointments effective February 7, 2024:
- Elyse Allan to move from her role as Chair of the Quality Committee to Chair of the Governance and Nominating Committee. Elyse will remain as a member of the Quality Committee.
- Jean-Robert Bernier to move from his role as Chair of the Governance and Nominating Committee to become Chair of the Quality Committee. Jean-Robert will remain as a member of the Governance and Nominating Committee.
- Neil Fraser be appointed as a member of Human Resources and Compensation Committee and Innovation and Transformation Committee.
- Tom Flynn be appointed as a member of Finance, Audit and Risk Committee and Quality Committee.
- Gillian Kernaghan to move from her role as a member of the Finance, Audit and Risk Committee to become a member of the Quality Committee.
- Cally Hunt to be appointed as a member of the Innovation and Transformation Committee.
The Board moved to a closed session due to the discussion of topics that are or may be subject to exemptions under the Freedom of Information and Protection of Privacy Act.
Termination of meeting
The meeting was adjourned at 5:10 p.m.
Upon motion duly made, seconded and unanimously carried the meeting was adjourned.
(Original signed by)
Catherine Zahn, Board Chair
(Original signed by)
Melissa McCready, Acting Corporate Secretary